To view this email as a web page, click here.
 
HIGHLIGHTS   |  April 12, 2019
 
MyPathway Subanalysis Backs Combination HER2-Targeting Antibodies in Colorectal Cancer
Investigators studied a combination of pertuzumab and trastuzumab in patients with metastatic, HER2-positive colorectal cancer.
Read more
 
Image IQ: A 48-Year-Old Man With Dyspnea and Cough
A 48-year-old man presents with dyspnea and cough. Imaging shows an anterior mediastinal mass, and resection of the mass is performed. What is your diagnosis?
Read more
 
IN CASE YOU MISSED IT
 
Which Breast Cancer Risk Models Are Most Accurate?
Researchers conducted a validation study of four breast cancer risk models currently in use.
Read more
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.